376
Views
17
CrossRef citations to date
0
Altmetric
Original Articles

Feasibility of Providing Interventions for Injection Drug Users in Pharmacy Settings: A Case Study among San Francisco Pharmacists

, Dr.P.H., M.P.H., , Ph.D. & , Ph.D.

REFERENCES

  • Appel, P.W.; Ellison, A.A.; Jansky, H.K. & Oldak, R. 2004. Barriers to enrollment in drug abuse treatment and suggestions for reducing them: Opinions of drug injecting street outreach clients and other system stakeholders. The American Journal of Drug and Alcohol Abuse 30 (1): 129–53.
  • Bernard, H.R.1995. Research Methods in Anthropology, Quantitative and Qualitative Approaches, 2nd ed. Walnut Creek, CA: Alta Mira Press.
  • Birkhead, G.S.; Klein, S.J.; Candelas, A.R.; O’Connell, D.A.; Rothman, J.R.; Feldman, I.S.; Tsui, D.S.; Cotroneo, R.A. & Flanigan, C.A. 2007. Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: A comprehensive approach. International Journal of Drug Policy 18 (5): 417–25.
  • Bluthenthal, R.N.; Kral, A.H.; Gee, L.; Lorvick, J.; Moore, L.; Seal, K. & Edlin, B.R. 2001. Trends in HIV seroprevalence and risk among gay and bisexual men who inject drugs in San Francisco, 1988 to 2000. Journal of Acquired Immune Deficiency Syndromes 28 (3): 264–69.
  • Bruneau, J.; Daniel, M.; Abrahamowicz, M.; Zang, G.; Lamothe, F. & Vincelette, J. 2011. Trends in human immunodeficiency virus incidence and risk behavior among injection drug users in Montreal, Canada: A 16-year longitudinal study. American Journal of Epidemiology 173 (9): 1049–58.
  • Centers for Disease Control and Prevention (CDC). 2010. Syringe exchange programs: 2008. MMWR: Morbidity and Mortality Weekly Report 59 (45): 1488–91.
  • Centers for Disease Control and Prevention (CDC). Walgreens, EBONY encourages Americans to “Be Greater than AIDS.” Available at: http://www.cdc.gov/nchhstp/newsroom/WalgreensPressRelease.html. Accessed August 4, 2011.
  • Chitwood, D.D.; McBride, D.C.; French, M.T. & Comerford, M. 1993. Health care need and utilization: A preliminary comparison of injection drug users, other illicit drug users, and nonusers. Substance Use Misuse 34 (4–5): 727–46.
  • Cooper, E.N.; Dodson, C.; Stopka, T.J.; Riley, E.D.; Garfein, R.S. & Bluthenthal, RN. 2007. Pharmacy participation in non-prescription syringe sales in Los Angeles and San Francisco Counties, 2007. Journal of Urban Health 87 (4): 543–52.
  • Cotton-Oldenburg, N.U.; Carr, P.; Deboer, J.M.; Collision, E.K. & Novotny, G. 2001. Impact of pharmacy-based syringe access on injection practices among injection drug users in Minnesota, 1998 to 1999. Journal of Acquired Immune Deficiency Syndromes 2 (2): 183–92.
  • Crawford, N.D.; Blaney, S.; Amesty, S.; Rivera, A.V.; Turner, A.K.; Ompad, D.C. & Fuller, C.M. 2011. Individual- and neighborhood-level characteristics associated with support of in-pharmacy vaccination among ESAP-registered pharmacies: Pharmacists’ role in reducing racial/ethnic disparities in influenza vaccinations in New York City. Journal of Urban Health 88 (1): 176–85.
  • Cunningham, C.O.; Sohler, N.L.; Cooperman, N.A.; Berg, K.M.; Litwin, A.H. & Arnsten, J.H. 2011. Strategies to improve access to and utilization of health care services and adherence to antiretroviral therapy among HIV-infected drug users. Substance Use Misuse 46 (2–3): 218–32.
  • Fuller, C.M.; Galea, S.; Caceres, W.; Blaney, S.; Sisco, S. & Vlahov, D. 2007. Multilevel community-based intervention to increase access to sterile syringes among injection drug users through pharmacy sales in New York City. American Journal of Public Health 97 (1): 117–24.
  • Gibson, D.R.; Brand, R.; Anderson, K.; Kahn, J.G.; Perales, D. & Guydish, J. 2002. Two- to sixfold decreased odds of HIV risk behavior associated with use of syringe exchange. Journal of Acquired Immune Deficiency Syndromes 31 (2): 237–42.
  • Grabenstein, J.D.; Guess, H.A.; Hartzema, A.G.; Koch, G.G. & Konrad, T.R. 2001. Effect of vaccination by community pharmacists among adult prescription recipients. Medical Care 39 (4): 340–8.
  • Heinzerling, K.G.; Kral, A.H.; Flynn, N.M.; Anderson, R.L.; Scott, A.; Gilbert, M.L.; Asch, S.M. & Bluthenthal, R.N. 2006. Unmet need for recommended preventive health services among clients of California syringe exchange programs: Implications for quality improvement. Drug and Alcohol Dependence 81 (2): 167–78.
  • Heinzerling, K.G.; Kral, A.H.; Flynn, N.M.; Anderson, R.L.; Scott, A.; Gilbert, M.L.; Asch, S.M. & Bluthenthal, R.N. 2007. Human immunodeficiency virus and hepatitis C virus testing services at syringe exchange programs: Availability and outcomes. Journal of SubstanceAbuse Treatment 32 (4): 423–9.
  • Jones, D.L.; Waldrop-Valverde, D.; Gonzalez, P.; Mack, A.; Kumar, A.M.; Ownby, R.; Weiss, S.M. & Kumar, M. 2010. Mental health in HIV seronegative and seropositive IDUs in South Florida, 2010. AIDS Care 22 (2): 152–8.
  • Kalister, H.; Newman, R.D.; Read, L.; Walters, C.; Hrachovec, J. & Graham, E.A. 1999. Pharmacy-based evaluation and treatment of minor illnesses in a culturally diverse pediatric clinic. Archives of Pediatrics and Adolescent Medicine 153 (7): 731–5.
  • Kidorf, M. & King, V.L. 2008. Expanding the public health benefits of syringe exchange programs. Canadian Journal of Psychiatry 53 (8): 487–95.
  • Kral, A.H.; Anderson, R.; Flynn, N.M. & Bluthenthal, R.N. 2004. Injection risk behaviors among clients of syringe exchange programs with different syringe dispensation policies. Journal of Acquired Immune Deficiency Syndromes 37 (2): 1307–12.
  • Lekas, H.M.; Siegel, K. & Leider, J. 2011. Felt and enacted stigma among HIV/HCV-coinfected adults, the impact of stigma layering. Qualitative Health Research 21 (9): 1205–19.
  • Lutnick, A.; Case, P. & Kral, A.H. 2012. Injection drug users’ perspectives on placing HIV prevention and other clinical services in pharmacy settings. Journal of Urban Health 89 (2): 354–364.
  • Lutnick, A.; Cooper, E.; Dodson, C.; Bluthenthal, R. & Kral, A. 2013. Pharmacy syringe purchase test of non-prescription syringe sales in San Francisco and Los Angeles, 2010. Journal of Urban Health 90 (2): 276–283.
  • MacDonald, M.; Law, M.; Kaldor, J.; Hales, J. & Dore, G. 2003. Effectiveness of needle and syringe programs for prevention HIV transmission. International Journal of Drug Policy 14 (5/6): 353–57.
  • Mathers, B.M.; Degenhardt, L.; Wiessing, A.H.; Hickman, M.; Matrick, P.; Myers, B.; Ambekar, A. & Strathdee, S.A. 2010. HIV prevention, treatment, and care services for people who inject drugs: A systematic review of global, regional, and national coverage. The Lancet 20 (375): 1014–28.
  • Mehta, S.H.; Genberg, B.L.; Astemborski, J.; Kavasery, R.; Kirk, G.D.; Vlahov, D.; Strathdee, S.A. & Thomas, D.L. 2008. Limited uptake of hepatitis C treatment among injection drug users. Journal of Community Health 33 (3): 126–33.
  • Miles, M.B. & Huberman, A.M. 1994. Qualitative Data Analysis, 2nd ed. Thousand Oaks, CA: Sage Publications.
  • Molitor, F.; Kuenneth, C.; Waltemeyer, J.; Mendoza, M.; Aguirre, A.; Brockmann, K. & Crump, C. 2005. Linking HIV-infected persons of color and injection drug users to HIV medical and other services: The California Bridge Project. AIDS Patient Care and STDs 19 (6): 406–12.
  • Pouget, E.R.; Deren, S.; Fuller, C.M.; Blaney, S.; McMahon, J.M.; Kang, S.Y.; Tortu, S.; Andia, J.F.; DesJarlais, D.C. & Vlahov, D. 2005. Receptive syringe sharing among injection drug users in Harlem and the Bronx during the New York State Expanded Syringe Access Demonstration Program. Journal of Acquired Immune Deficiency Syndromes 39 (4): 471–7.
  • Reich, W.; Compton, W.M.; Horton, J.C.; Cotler, L.B.; Cunningham-Williams, R.M.; Booth, R.; Singer, M.; Leukefeld, C.; Fink, J.; Stopka, T.J.; Corsi, K.F. & Tindall, M.S. 2002. Injection drug users report good access to pharmacy sale of syringes. Journal of the American Pharmaceutical Association (Wash) 42 (6 Suppl 2): S68–72.
  • Rich, J.D.; Hogan, J.W.; Wolf, F.; DeLong, A.; Zaller, N.D.; Mehrotra, M. & Reinert, S. 2007. Lower syringe sharing and re-use after syringe legalization in Rhode Island. Drug and Alcohol Dependence 89 (2–3): 292–7.
  • Riley, E.D.; Kral, A.H.; Stopka, T.J.; Garfein, R.S.; Reuckhaus, P. & Bluthenthal, R.N. 2010. Access to sterile syringes through San Francisco pharmacies and the association with HIV risk behavior among injection drug users. Journal of Urban Health 87 (4): 534–42.
  • Riley, E.D.; Wu, A.W.; Junge, B.; Marx, M.; Strathdee, S.A. & Vlahov, D. 2002. Health services utilization by injection drug users participating in a needle exchange program. The American Journal of Drug and Alcohol Abuse 28 (3): 497–511.
  • Rose, V.J. & Raymond, H.F. 2010. Evaluation of nonprescription syringe sales in San Francisco. Journal of the American Pharmacists Association 50 (5): 595–9.
  • Rudolph, A.E.; Standish, K.; Amesty, S.; Crawford, N.D.; Stern, R.J.; Badillo, W.E.; Boyer, A.; Brown, D.; Ranger, N.; Orduna, J.M.; Lasenburg, L.; Lippek, S. & Fuller, C.M. 2010. A community based approach to linking injecting drug users with needed services through pharmacies: An evaluation of a pilot intervention in New York City. AIDS Education and Prevention 22 (3): 238–51.
  • Singer, M.; Baer, H.; Scott, G.; Horowitz, S. & Weinstein, B. 1998. Pharmacy access to syringes among injection drug users: Follow-up findings from Hartford, Connecticut. Public Health Reports 113 (Suppl 1): 81–9.
  • Strauss, A. & Corbin, J. 1988. Basics of Qualitative Research: Techniques and Procedures for Developing Grounded Theory, 2nd ed. Thousand Oaks, CA: Sage Publications.
  • Walgreens. Free HIV testing at select Walgreens. Available at: http://www.greaterthan.org/2011/06/walgreens-free-hiv-testing-locations. Accessed August 4, 2011.
  • Walton, G.; Co, S.J.; Milloy, M.J.; Qi, J.; Kerr, T. & Wood, E. 2011. High prevalence of childhood emotional, physical and sexual trauma among a Canadian cohort of HIV-seropositive illicit drug users. AIDS Care 23 (6): 714–21.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.